EMA Likes Rituximab Biosimilar, Other Cancer Drugs EMA Likes Rituximab Biosimilar, Other Cancer Drugs

A rituximab biosimilar has been recommended for full approval in Europe for use in blood cancers.International Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news